Capecitabine 500mg""'''

Capecitabine
CAPECITIME  is an oral chemotherapy medication that is used to treat certain types of cancer, including breast cancer and colorectal cancer. It's converted into its active form in the body and works by interfering with the growth and replication of cancer cells. CAPECITIME  is sold under the brand name Xeloda.
Here's some key information about CAPECITIME :
Mechanism of Action: CAPECITIME  is a prodrug, meaning it is converted into its active form, fluorouracil (5-FU), within the body. Fluorouracil is an antimetabolite that disrupts the DNA and RNA synthesis necessary for the growth of cancer cells, leading to their destruction.
Breast Cancer: CAPECITIME  is often used in the treatment of advanced or metastatic breast cancer that is no longer responding to other treatments. It can be used as a single agent or in combination with other chemotherapy drugs.
Colorectal Cancer: CAPECITIME  is also used in the treatment of colorectal cancer, particularly when the cancer has spread to other parts of the body (metastatic colorectal cancer). It can be used alone or in combination with other medications.
Dosage: The dosage of CAPECITIME  can vary based on individual patient characteristics, the type of cancer being treated, and the treating physician's recommendations. It's usually taken as an oral tablet, typically twice a day.
Side Effects: Common side effects of CAPECITIME  can include nausea, vomiting, diarrhea, hand-foot syndrome (palmar-plantar erythrodysesthesia) characterized by redness, swelling, and pain in the palms of the hands and soles of the feet, fatigue, and decreased blood cell counts.
Precautions:
Liver and Kidney Function: CAPECITIME  is metabolized by the liver and excreted by the kidneys, so it's important to monitor liver and kidney function during treatment.
Pregnancy and Breastfeeding: CAPECITIME  can cause harm to the developing fetus, so it should not be used during pregnancy. It can also pass into breast milk, so its use should be avoided while breastfeeding.
Monitoring: Regular monitoring by a healthcare provider is important during treatment with CAPECITIME  to assess its effectiveness, manage potential side effects, and adjust the dosage if needed.
Discontinuation: The decision to discontinue or modify treatment with CAPECITIME  should be made in consultation with the healthcare provider.
Combination Therapy: CAPECITIME  is often used in combination with other chemotherapy drugs or targeted therapies, depending on the specific cancer being treated.
For further information please contact:
info@sterispharma.com
order now: - https://www.sterisonline.com/product/capecitime-500-133655